GENEVA, July 2 -- APERTURE THERAPEUTICS, INC. filed a patent application (US2025/060804) for “COMPOSITIONS FOR MODULATING MMP9 EXPRESSION AND USES THEREOF”. With publication no. WO/2026/136976, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....